Effect of contrast leakage on the detection of abnormal brain tumor vasculature in high-grade glioma

Journal of Neuro-Oncology

Volumn 116, Issue 3, 2014, Pages 543-549

  Laviolette, Peter S ^a   Daun, Mitchell K ^a   Paulson, Eric S ^a   Schmainda, Kathleen M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Brain Tumor; Dynamic Susceptibility Contrast (DSC); Glioblastoma; Independent Component Analysis (ICA); Perfusion MRI

Indexed keywords

ADULT; AGED; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; CONTRAST MEDIA; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PRINCIPAL COMPONENT ANALYSIS; YOUNG ADULT;

EID: 84894083764     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1318-9     Document Type: Article

References (36)

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109
2. Deane BR, Lantos PL (1981) The vasculature of experimental brain tumours. Part 1. A sequential light and electron microscope study of angiogenesis. J Neurol Sci 49:55-66
3. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6
4. Millauer B, Shawver LK, Plate KH, Risau W, Ullrich A (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature 367:576-579
5. Leon SP, Folkerth RD, Black PM (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362-372
6. Lev MH, Rosen BR (1999) Clinical applications of intracranial perfusion MR imaging. Neuroimaging Clin N Am 9:309-331
7. Cha S, Lu S, Johnson G, Knopp EA (2000) Dynamic susceptibility contrast MR imaging: correlation of signal intensity changes with cerebral blood volume measurements. J Magn Reson Imaging 11:114-119
8. Covarrubias DJ, Rosen BR, Lev MH (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528-537
9. Gahramanov S, Raslan AM, Muldoon LL, Hamilton BE, Rooney WD, Varallyay CG, Njus JM, Haluska M, Neuwelt EA (2011) Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility- weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study. Int J Radiat Oncol Biol Phys 79:514-523
10. Barajas RF Jr, Chang JS, Segal MR, Parsa AT, McDermott MW, Berger MS, Cha S (2009) Differentiation of recurrent glioblastoma multiforme from radiation necrosis after external beam radiation therapy with dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging. Radiology 253:486-496
11. Hoefnagels FW, Lagerwaard FJ, Sanchez E, Haasbeek CJ, Knol DL, Slotman BJ, Vandertop WP (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878-887
12. Hu LS, Baxter LC, Smith KA, Feuerstein BG, Karis JP, Eschbacher JM, Coons SW, Nakaji P, Yeh RF, Debbins J, Heiserman JE (2009) Relative cerebral blood volume values to differentiate high-grade glioma recurrence from posttreatment radiation effect: direct correlation between image-guided tissue histopathology and localized dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging measurements. AJNR Am J Neuroradiol 30:552-558
13. Sugahara T, Korogi Y, Tomiguchi S, Shigematsu Y, Ikushima I, Kira T, Liang L, Ushio Y, Takahashi M (2000) Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 21:901-909
14. LaViolette PS, Cohen AD, Prah MA, Rand SD, Connelly J, Malkin MG, Mueller WM, Schmainda KM (2013) Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma. Neuro Oncol 15:442-450
15. Paulson ES, Schmainda KM (2008) Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 249:601-613
16. Beckmann CF, Smith SM (2004) Probabilistic independent component analysis for functional magnetic resonance imaging. IEEE Trans Med Imaging 23:137-152
17. Hyvarinen A (1999) Fast and robust fixed-point algorithms for independent component analysis. IEEE Trans Neural Netw 10:626-634
18. LaViolette PS, Cohen AD, Schmainda KM (2012) Contrast leakage in high grade glioma measured with independent component analysis of dynamic susceptibility contrast MRI. Proc ISMRM, Melbourne
19. Cox RW (1996) AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29:162-173
20. Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D (2003) Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989-1998
21. Knopp EA, Cha S, Johnson G, Mazumdar A, Golfinos JG, Zagzag D, Miller DC, Kelly PJ, Kricheff II (1999) Glial neoplasms: dynamic contrast-enhanced T2-weighted MR imaging. Radiology 211:791-798
22. Aronen HJ, Gazit IE, Louis DN, Buchbinder BR, Pardo FS, Weisskoff RM, Harsh GR, Cosgrove GR, Halpern EF, Hochberg FH et al (1994) Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 191:41-51
23. Sugahara T, Korogi Y, Shigematsu Y, Liang L, Yoshizumi K, Kitajima M, Takahashi M (1999) Value of dynamic susceptibility contrast magnetic resonance imaging in the evaluation of intracranial tumors. Top Magn Reson Imaging 10:114-124
24. Sugahara T, Korogi Y, Kochi M, Ikushima I, Hirai T, Okuda T, Shigematsu Y, Liang L, Ge Y, Ushio Y, Takahashi M (1998) Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 171:1479-1486
25. Wong ET, Jackson EF, Hess KR, Schomer DF, Hazle JD, Kyritsis AP, Jaeckle KA, Yung WK, Levin VA, Leeds NE (1998) Correlation between dynamic MRI and outcome in patients with malignant gliomas. Neurology 50:777-781
26. Boxerman JL, Schmainda KM, Weisskoff RM (2006) Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 27:859-867
27. Hu LS, Baxter LC, Pinnaduwage DS, Paine TL, Karis JP, Feuerstein BG, Schmainda KM, Dueck AC, Debbins J, Smith KA, Nakaji P, Eschbacher JM, Coons SW, Heiserman JE (2010) Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol 31:40-48
28. Spampinato MV, Wooten C, Dorlon M, Besenski N, Rumboldt Z (2006) Comparison of first-pass and second-bolus dynamic susceptibility perfusion MRI in brain tumors. Neuroradiology 48:867-874
29. McKeown MJ, Makeig S, Brown GG, Jung TP, Kindermann SS, Bell AJ, Sejnowski TJ (1998) Analysis of fMRI data by blind separation into independent spatial components. Hum Brain Mapp 6:160-188
30. Calhoun VD, Liu J, Adali T (2009) A review of group ICA for fMRI data and ICA for joint inference of imaging, genetic, and ERP data. Neuroimage 45:S163-S172
31. Onton J, Westerfield M, Townsend J, Makeig S (2006) Imaging human EEG dynamics using independent component analysis. Neurosci Biobehav Rev 30:808-822
32. Kao YH, Guo WY, Wu YT, Liu KC, Chai WY, Lin CY, Hwang YS (2003) Jy-Kang Liou A, Wu HM, Cheng HC, Yeh TC, Hsieh JC, Mu Huo Teng M: Hemodynamic segmentation of MR brain perfusion images using independent component analysis, thresholding, and Bayesian estimation. Magn Reson Med 49:885-894
33. LaViolette PS, Cohen AD, Rand SD, Mueller WM, Schmainda KM (2011) Independent component analysis of dynamic susceptibility contrast MRI in brain tumor: a new biomarker for measuring tumor perfusion patterns. Proc ISMRM, Montreal Quebec
34. Senger DR, Van de Water L, Brown LF, Nagy JA, Yeo KT, Yeo TK, Berse B, Jackman RW, Dvorak AM, Dvorak HF (1993) Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastasis Rev 12:303-324
35. LaViolette PS, Daun M, Cohen AD, Connelly J, Schmainda KM (2013) Optimizing repeatability of independent component analysis applied to dynamic susceptibility contrast MRI in 68 brain tumor patients with five repeated scans. In: Proceedings of the 21st Annual Meeting of ISMRM Salt Lake City
36. LaViolette PS, Daun M, Prah M, Jafari-Khouzani K, Polaskova P, Gerstner ER, Stufflebeam SM, Schmainda KM (2013) Repeatability of Independent Component Analysis applied to Dynamic Susceptibility Contrast MRI in Newly Diagnosed Brain Tumor Patients with Two Baseline Imaging Scans. In: Proceedings of the 21st Annual Meeting of ISMRM Salt Lake City